Literature DB >> 2845890

An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.

S Sakuma1, M Yamamoto, Y Kumano, R Mori.   

Abstract

Herpes simplex virus type 2 (HSV-2), strain YS-4 C-1, isolated by plaque cloning from a clinical isolate was found to be resistant to acyclovir (ACV; acycloguanosine) in vitro. It was sensitive to phosphonoacetic acid and 9-beta-D-arabinofuranosyladenine. Thymidine kinase (TK) activity of YS-4 C-1 was less than 1% of that of other strains from the same clinical source. However, thymidine plaque autoradiography showed that YS-4 C-1 was not completely deficient in TK activity. YS-4 C-1 showed high virulence for mice like other HSV-2 strains which were sensitive to ACV. YS-4 C-1 was able to establish latent infection in mice. Virus isolated from the brain of a mouse died after being inoculated with YS-4 C-1 was also resistant to ACV. ACV was not effective in mice inoculated with YS-4 C-1. This study shows that not all ACV-resistant strains are avirulent for mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845890     DOI: 10.1007/bf01310998

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  37 in total

1.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  L R Stanberry; S Kit; M G Myers
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  A novel selective broad-spectrum anti-DNA virus agent.

Authors:  E De Clercq; A Holý; I Rosenberg; T Sakuma; J Balzarini; P C Maudgal
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

3.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

4.  Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.

Authors:  H J Field; B A Larder; G Darby
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

5.  Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses.

Authors:  R B Tenser; J C Jones; S J Ressel; F A Fralish
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

6.  Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child.

Authors:  C D Sibrack; L T Gutman; C M Wilfert; C McLaren; M H St Clair; P M Keller; D W Barry
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

7.  Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.

Authors:  G Darby; H J Field; S A Salisbury
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

8.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.

Authors:  H J Field; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.

Authors:  P C Maudgal; E De Clercq; P Huyghe
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-02       Impact factor: 4.799

10.  Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.

Authors:  H J Field; E Lay
Journal:  Antiviral Res       Date:  1984-04       Impact factor: 5.970

View more
  6 in total

1.  Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.

Authors:  T Suzutani; M Saijo; M Nagamine; M Ogasawara; M Azuma
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Characterization of glycoprotein C-negative mutants of herpes simplex virus type 1 isolated from a patient with keratitis.

Authors:  Y Hidaka; S Sakuma; Y Kumano; H Minagawa; R Mori
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Gastrointestinal invasion by herpes simplex virus type 1 inoculated cutaneously into the immunosuppressed mice.

Authors:  H Takase; E Yamamura; Y Murakami; T Ikeuchi; Y Osada
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

Authors:  S Tanaka; Y Toh; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Nucleotide sequence of the major DNA-binding protein gene of herpes simplex virus type 2 and a comparison with the type 1.

Authors:  Y Toh; Y Liu; S Tanaka; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.

Authors:  S H Pincus; K Wehrly; E Tschachler; S F Hayes; R S Buller; M Reitz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.